Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP23434.RAtNJQqtcEGmilFWnrp-K89UYjTsCNmmCADY5jI06UOzY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP23434.RAtNJQqtcEGmilFWnrp-K89UYjTsCNmmCADY5jI06UOzY130_assertion type Assertion NP23434.RAtNJQqtcEGmilFWnrp-K89UYjTsCNmmCADY5jI06UOzY130_head.
- NP23434.RAtNJQqtcEGmilFWnrp-K89UYjTsCNmmCADY5jI06UOzY130_assertion description "[Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP23434.RAtNJQqtcEGmilFWnrp-K89UYjTsCNmmCADY5jI06UOzY130_provenance.
- NP23434.RAtNJQqtcEGmilFWnrp-K89UYjTsCNmmCADY5jI06UOzY130_assertion evidence source_evidence_curated NP23434.RAtNJQqtcEGmilFWnrp-K89UYjTsCNmmCADY5jI06UOzY130_provenance.
- NP23434.RAtNJQqtcEGmilFWnrp-K89UYjTsCNmmCADY5jI06UOzY130_assertion SIO_000772 19204207 NP23434.RAtNJQqtcEGmilFWnrp-K89UYjTsCNmmCADY5jI06UOzY130_provenance.
- NP23434.RAtNJQqtcEGmilFWnrp-K89UYjTsCNmmCADY5jI06UOzY130_assertion wasDerivedFrom ctd_human-2016 NP23434.RAtNJQqtcEGmilFWnrp-K89UYjTsCNmmCADY5jI06UOzY130_provenance.
- NP23434.RAtNJQqtcEGmilFWnrp-K89UYjTsCNmmCADY5jI06UOzY130_assertion wasGeneratedBy ECO_0000218 NP23434.RAtNJQqtcEGmilFWnrp-K89UYjTsCNmmCADY5jI06UOzY130_provenance.